Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-11-005320
Filing Date
2011-05-18
Accepted
2011-05-18 16:58:19
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 a2202760z424b5.htm 424B5 416012
2 G148431.JPG g148431.jpg GRAPHIC 16723
  Complete submission text file 0001047469-11-005320.txt   440341
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-165899 | Film No.: 11855452
SIC: 2835 In Vitro & In Vivo Diagnostic Substances